Business Litigation

Complex Business Litigation Attorneys

The U. S. Consumer Product Safety Commission (CPSC) has issued safety warnings relating to self-balancing scooters, commonly known as HoverBoards. The CPSC is the federal regulatory agency responsible for protecting consumers from unreasonable risks of injury and death from consumer products. The CPSC warning advised companies that import, manufacture, distribute, or sell Hoverboards in the United States that they comply with currently applicable safety standards, including all referenced standards and requirements contained in UL 2272 – Outline of Investigation for Electrical Systems for Self-balancing Scooters. The UL standard can be purchased from Underwriters Laboratories Inc. (http://www.comm-2000.com/). Additionally, all lithium ion battery products must comply with test requirements under UN/DOT 38.3 Transport of Dangerous Goods for Lithium Metal and Lithium Ion Batteries. The CPSC believes that certain Hoverboards do not meet these voluntary safety standards and that they pose an unreasonable risk of fire to consumers. Moreover, the CPSC advised that consumers risk serious injury or death if their self- balancing scooters ignite and burn. From December 1, 2015, through February 17, 2016, CPSC received reports, from consumers in 24 states, of 52 self-balancing scooter fires resulting in over $2 million in property damage, including the destruction of two homes and an automobile. CPSC believes that many of the reported incidents, and the related unreasonable risk of injuries and deaths associated with fires in these products, would be prevented if all Hoverboards were manufactured in compliance with the safety standards. If you, or a loved one have purchased a Hoverboard you should be aware of fire dangers. The lawyers at Napoli Shkolnik, PLLC are representing consumers who want refunds for defective Hoverboards or who have been injured by these defective Hoverboards.  
Dupixent Cancer Risk: What Patients Need to Know About CTCL

Emerging Research Raises Questions About Dupixent’s Safety Profile  Dupixent (dupilumab) has become one of the most widely prescribed biologic medications for chronic inflammatory conditions, helping over one million patients...

Read the Article
Talcum Powder and Ovarian Cancer Risk: What Consumers Need to Know Now 

In recent years, talcum powder has moved from a household staple to the center of widespread litigation and scientific scrutiny. A growing body of research and high-profile jury verdicts has...

Read the Article
Depo-Provera: What Women Should Know About the Birth Control Shot and Meningioma Risk

Depo-Provera has been widely used for decades as a convenient form of birth control. Administered as an injection every three months, the contraceptive shot offers a highly effective...

Read the Article

Our Locations

Please Contact Us for an In-Person Appointment